We entered a long position on PEOPLE/USDT at 0.06377 on the 4th of October. The trade has progressed well, reaching TP 3 (0.08002) and now almost touching TP 4 (0.08385). A trailing stop has been set at 0.06812 to protect gains as we aim for the final target.
Target Points:
This trade showcases the accuracy of the Risological Swing Trader in capturing profitable setups with precision—an essential tool for future market opportunities.
We’ll continue to monitor the trade closely as it nears the final target.
Target Points:
- TP 1: 0.06761
- TP 2: 0.07381
- TP 3: 0.08002 (hit)
- TP 4: 0.08385 (almost reached)
- Trailing Stop: 0.06812
- Stop Loss (SL): 0.06067
This trade showcases the accuracy of the Risological Swing Trader in capturing profitable setups with precision—an essential tool for future market opportunities.
We’ll continue to monitor the trade closely as it nears the final target.
Note
Take Profit level 4 (TP4) DONE!!!Congratulations holders!
Note
Take Profit 4 (TP 4) done!- Supercharge your trading with > Risological.com
- 30-Day Money Back Guarantee!
- Accurate Entry, Stoploss and Take Profit levels
- NO Repaint
- Detects Sideways Market
- Limited time discount available. HURRY!
- 30-Day Money Back Guarantee!
- Accurate Entry, Stoploss and Take Profit levels
- NO Repaint
- Detects Sideways Market
- Limited time discount available. HURRY!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
- Supercharge your trading with > Risological.com
- 30-Day Money Back Guarantee!
- Accurate Entry, Stoploss and Take Profit levels
- NO Repaint
- Detects Sideways Market
- Limited time discount available. HURRY!
- 30-Day Money Back Guarantee!
- Accurate Entry, Stoploss and Take Profit levels
- NO Repaint
- Detects Sideways Market
- Limited time discount available. HURRY!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.